Covance Clinical Research Unit

Madison, Wisconsin 53718

0 studies enrolling now · 37 studies all time

What they study most

ADME, Arthritis, Bacterial Infections, Chronic Hepatitis C Infection, Fragile X Syndrome, Healthy, Healthy Subjects, Healthy Volunteer, Healthy Volunteers, Heart Decompensation, Acute, Hematopoietic Syndrome Due to Acute Radiation Syndrome, Influenza

Studies at this site

• A Phase I Study to Investigate the Absorption, Metabolism and Excretion in Healthy Male Subjects — Completed
• Study to Evaluate the Drug-drug Interactions Between Metformin and AMG 510 in Healthy Participants — Completed
• A Drug Drug Interaction (DDI) Study of Pirtobrutinib (LOXO-305) and Digoxin (P-Glycoprotein Substrate) in Healthy Participants — Completed
• A Study of (14C) Radiolabeled JNJ-56136379 in Healthy Male Participants — Completed
• A Study of Carbon-14-Labelled [14C] LOXO-305 (Pirtobrutinib) in Healthy Male Participants — Completed
• A Study of Carbon-14-Labelled [14C] LY3871801 in Healthy Male Participants — Completed
• A Study of LY3410738 in Healthy Adult Participants — Completed
• A Study to Evaluate the Mass Balance of 14C-Napabucasin in Healthy Adult Male Subjects — Completed
• A Study of LY3337641 in Healthy Male Participants — Completed
• A Study of Carbon-14-Labelled [14C] LY3437943 in Healthy Male Participants — Completed
• Pharmacokinetics and Excretion of Oral [14C]-Rodatristat Ethyl — Completed
• Absorption, Metabolism, and Excretion (AME) Study of [14C]EDP-938 in Healthy Male Subjects — Completed
• Phase 1 Study to Evaluate ASN002 Absorption, Metabolism, and Excretion of [14C] Following a Single Oral Dose in Healthy Male Subjects — Completed
• Absorption, Metabolism and Excretion of [14C]-Lasmiditan - Single Oral Dose Administration — Completed
• 2-part Study to Assess Safety, Pharmacokinetics & Pharmacodynamics of CC-220 & Effect of Food on CC-220 in Healthy Subjects — Completed
• A Drug-drug Interaction Study to Investigate the Effect of Coadministration of EDP-305 on the PK of a Combined Oral Contraceptive in Healthy Female Subjects — Completed
• Study to Determine the Safety, Tolerability, and Pharmacokinetic (PK) Profile of EGT0001474 in Healthy Volunteers — Completed
• Phase 1 LEP-F1 + GLA-SE Vaccine Trial in Healthy Adult Volunteers — Completed
• A Study of the Absorption, Metabolism, and Excretion of Tucatinib in Healthy Participants — Completed
• Absorption, Metabolism and Excretion (AME) Study of [14C]EDP-305 in Healthy Male Subjects — Completed
• Safety and Tolerability of HemaMax™ (rHuIL-12) as Radiation Countermeasure — Completed
• Safety Study of HemaMax™ (rHuIL-12) to Treat Acute Radiation Syndrome — Completed
• A Study of the Safety, Tolerability, and Absorption, Metabolism, and Excretion of PA-824 in Healthy Adult Male Subjects. — Completed
• Radiolabeled Study of CC-220 in Healthy Male Subjects — Completed
• Single and Multiple Ascending Dose Pharmacokinetic Study of TR701 in Healthy Adults — Completed
• Pharmacokinetics and Metabolism of [14C] BMS-986231 in Healthy Male Participants — Completed
• Pharmacokinetics and Metabolism Study of Radiolabeled BMS-986142 in Healthy Male Subjects — Completed
• Ascending Dose Pharmacokinetic (PK) and Absolute Bioavailability (BA) — Completed
• An Open-label, Single-dose Study to Determine the Metabolism and Excretion of [14C]E2006 in Healthy Male Subjects — Completed
• Study to Assess Safety, Tolerability, and Pharmacokinetics of Oral Doses for AC430 in Healthy Subjects — Completed
• AZD0914 Phase 1 ADME Study in Healthy Volunteers — Completed
• AME Study of [14C]-YH4808 in Healthy Male Subjects — Completed
• 3-part Study to Evaluate Safety, Tolerability, Pharmacokinetics & Pharmacodynamics of Multiple Doses of CC-220 and Relative Bioavailability of a Formulated CC-220 Capsule — Completed
• Evaluation of Safety and Pharmacokinetics of Single Doses of VBY-376 in Healthy Adults — Completed
• Safety Study of Single Administration Intravenous Treatment for Influenza — Stopped early
• A Phase I, Open Interaction Study Between GLPG0634 and Midazolam in Healthy Subjects — Completed
• A Single-Dose Study in Normal Volunteers to Assess the Safety, Tolerability and Pharmacokinetics of STX107 — Completed